TCBP: Volume dana dhuwit perusahaan TC BioPharm

Logo perusahaan publik tcbiopharm.com (TCBP)

The high potential of TC Biopharm (TCBP) is driven by the creation of universal cell-based therapies available to patients instantaneously. The cash reserve history visualizes liquidity dynamics, where 0.00 determines the latest valuation metric. The company's growth relies on the development of leukemia therapy and FDA support, while its scaling strategy is based on alliances with oncology centers without utilizing mergers.

Cadangan dhuwit perusahaan: TC BioPharm (Holdings) PLC (TCBP) kanggo 28.04.2023 - 29.03.2025

Rincian metrik keuangan lan pasar TC BioPharm (TCBP)

- kuotasi lan prakiraan analis:
Analisis komprehensif perusahaan:TCBP TC Biopharm
Produk merek tcbiopharm.com

The status of the British developer within a secure Western perimeter minimizes external risks for TC Biopharm. Analyzing current cash levels, the investor assesses the liquidity required to sustain scientific activities. This metric measures the volume of available capital, preventing cash flow gaps as borrowing costs rise. An optimal balance of funds ensures financial autonomy without sacrificing development momentum. A sufficient cash reserve guarantees the preservation of patents and research.

Pesaing langsung

Volume dana dhuwit perusahaan ARGX|BioNTech - Dhuwit awis lan setara dhuwit awis perusahaan|Volume dana dhuwit perusahaan ABVX (abivax.com)|Sisa dhuwit perusahaan ADMA|Protagonist Therapeutics, Inc. - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Immunovant, Inc.|KNSA: Volume dana dhuwit perusahaan|GRFS - Aset likuid perusahaan|ADPT (Adaptive Biotechnologies Inc.) - Volume dana dhuwit perusahaan|CLDX: Sisa dhuwit perusahaan|Dana dhuwit perusahaan Aurinia Pharmaceuticals Inc. (AUPH)|Dana dhuwit perusahaan BCRX (BioCryst Pharmaceuticals Inc)|Volume dana dhuwit perusahaan VERA (Vera Corp)|Gunggung dana dhuwit perusahaan DNTH (Dianthus Therapeutics)|PHVS - Dana dhuwit perusahaan|ABCL: Dana dhuwit perusahaan|TRML: Volume dana dhuwit perusahaan|Dhuwit awis perusahaan Precigen, Inc.|Dhuwit awis perusahaan PHAR|Nektar Therapeutics - Total volume dana dhuwit perusahaan|Dana dhuwit perusahaan Upstream Bio Corp (UPB)|Dhuwit awis perusahaan Zenas Biopharma ZBIO|Dana dhuwit perusahaan Immunome Bio IMNM|GOSS: Dhuwit awis lan setara dhuwit awis perusahaan|kalvista.com - Volume dana dhuwit perusahaan|SEPN (septerna.com) - Dhuwit awis lan setara dhuwit awis perusahaan|PVLA (Pieris Pharmaceuticals) - Dhuwit awis perusahaan|Savara - Sisa dhuwit perusahaan|RIGL (Rigel Corp) - Volume dana dhuwit perusahaan|Volume dana dhuwit perusahaan AnaptysBio Corp|Dana dhuwit perusahaan astriatx.com (ATXS)|Dhuwit awis perusahaan enGene ENGN|Dana dhuwit perusahaan RAPT Therapeutics, Inc. RAPT|JBIO - Dhuwit awis perusahaan|Aclaris Therapeutics Inc. - Volume dana dhuwit perusahaan|KYTX - Volume dana dhuwit perusahaan|TLSA (Tiziana Life Sciences PLC) - Dhuwit awis perusahaan|cabalettabio.com (CABA) - Volume dana dhuwit perusahaan|Dana dhuwit perusahaan Ventyx Biosciences|THTX (Theratechnologies) - Gunggung dana dhuwit perusahaan|Dhuwit awis perusahaan AVTX (Avalo Therapeutics Inc.)|Dana dhuwit perusahaan ELDN (Eledon)|Volume dana dhuwit perusahaan AGEN (Agenus, Inc)|Aset likuid perusahaan climbbio.com (CLYM)|zurabio.com - Volume dana dhuwit perusahaan|ATYR - Volume dana dhuwit perusahaan|ADAG: Volume dana dhuwit perusahaan|Ikena Oncology, Inc. (IMA) - Volume dana dhuwit perusahaan|STTK (Shattuck Therapeutics) - Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan equilliumbio.com EQ|Volume dana dhuwit perusahaan CNTB|IMUX - Cadangan dhuwit perusahaan|Dana dhuwit perusahaan Atara Biotherapeutics ATRA|Aset likuid perusahaan InflaRx N.V. (IFRX)|XFOR: Dhuwit awis perusahaan|adicetbio.com (ACET) - Dhuwit awis perusahaan|CELU: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan INmune Bio (INMB)|Dana dhuwit perusahaan Barinthus Bio|Dhuwit awis lan setara dhuwit awis perusahaan KZR (Kezar Life Sciences, Inc)|Dhuwit awis perusahaan SABS (SAB Biotherapeutics Inc)|Akari Therapeutics - Dhuwit awis lan setara dhuwit awis perusahaan|Enlivex Therapeutics Ltd - Dhuwit awis perusahaan|Sisa dhuwit perusahaan QTTB|GOVX - Dana dhuwit perusahaan|Cadangan dhuwit perusahaan Edesa|IBIO: Volume dana dhuwit perusahaan|Cadangan dhuwit perusahaan Carisma Therapeutics Inc (CARM)|Dana dhuwit perusahaan XTL Biopharmaceuticals, Ltd.|Dana dhuwit perusahaan BOLT|Dhuwit awis perusahaan HCWB (HCW Biologics, Inc.)|Gunggung dana dhuwit perusahaan APVO|AIM ImmunoTech - Dhuwit awis perusahaan|Sisa dhuwit perusahaan ADTX|GRI - Dana dhuwit perusahaan|XRTX (XORTX Therapeutics Inc) - Dhuwit awis lan setara dhuwit awis perusahaan|HIND: Volume dana dhuwit perusahaan|REVB (Revelation Bio) - Dana dhuwit perusahaan|Dana dhuwit perusahaan Indaptus|Scinai Immunotherapeutics (SCNI) - Aset likuid perusahaan|Volume dana dhuwit perusahaan CALI|Dhuwit awis perusahaan Affimed NV AFMD|Dana dhuwit perusahaan Allakos Inc ALLK|HOOK (HOOKIPA) - Total volume dana dhuwit perusahaan|IGM Biosciences - Volume dana dhuwit perusahaan|ITOS - Volume dana dhuwit perusahaan|Ocean Biomedical Corp (OCEA) - Dana dhuwit perusahaan|Dhuwit awis lan setara dhuwit awis perusahaan THRD